Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
25%
Ph phase_2
2
25%
Ph not_applicable
3
38%
Ph phase_4
1
13%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(1)
Other(2)

Detailed Status

Recruiting4
unknown2
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 22 (25.0%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

recruiting450%
unknown225%
completed113%
not_yet_recruiting113%

Recent Activity

4 active trials
Showing 5 of 8
not_yet_recruitingphase_4

Abemaciclib Dose Escalation in Early High-Risk Breast Cancer Adjuvant Therapy

NCT07599137
recruitingnot_applicable

Advanced Techniques For Single-fraction Palliative Radiotherapy Versus Standard Multi Fraction Radiation

NCT04649125
recruitingnot_applicable

FMISO-based Adaptive Radiotherapy for Head and Neck Cancer

NCT05348486
recruitingphase_1

The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation

NCT06792682
recruitingphase_1

A Study of GQ1010 in Subjects With Advanced Solid Tumors

NCT06464055
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07599137Phase 4

Abemaciclib Dose Escalation in Early High-Risk Breast Cancer Adjuvant Therapy

Not Yet Recruiting
NCT04649125Not Applicable

Advanced Techniques For Single-fraction Palliative Radiotherapy Versus Standard Multi Fraction Radiation

Recruiting
NCT05348486Not Applicable

FMISO-based Adaptive Radiotherapy for Head and Neck Cancer

Recruiting
NCT06792682Phase 1

The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation

Recruiting
NCT06464055Phase 1

A Study of GQ1010 in Subjects With Advanced Solid Tumors

Recruiting
NCT04121195Phase 2

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load

Completed
NCT04933357Phase 2

Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy 

Unknown
NCT02336711Not Applicable

Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8